|
|
Xarelto (rivaroxaban) is an anticoagulant used to prevent and treat blood clots by inhibiting Factor Xa, reducing the risk of stroke, deep vein thrombosis, and pulmonary embolism.
|
|
10mg
28pills |
|
$67.19
$55.99 $2.00 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $0.00 |
|
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
10mg
56pills |
|
|
$67.19
$55.99 $1.00 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $56.00 |
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
15mg
28pills |
|
$117.59
$97.99 $3.50 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $0.00 |
|
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
15mg
56pills |
|
|
$167.99
$139.99 $2.50 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $56.00 |
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
20mg
28pills |
|
|
$134.39
$111.99 $4.00 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $0.00 |
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
20mg
56pills |
|
|
$201.59
$167.99 $3.00 per pill |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $56.00 |
|
+ Package delivery insurance + Next orders 10% discount |
|||||
October
![]() |
|
Delivery period 14-21 days |
14.95$ | Tracking# available in 4 days |
![]() |
|
Delivery period 9-14 days |
30$ | Tracking# available in 2 days |
Common use
Xarelto (rivaroxaban) is a direct oral anticoagulant (DOAC) belonging to the class of Factor Xa inhibitors, prescribed for multiple cardiovascular and thromboembolic conditions. It is widely used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, to treat and prevent recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of blood clot formation following hip or knee replacement surgery. Xarelto works by selectively and reversibly inhibiting Factor Xa, a critical enzyme in the coagulation cascade responsible for converting prothrombin to thrombin and ultimately forming blood clots. Unlike older anticoagulants such as warfarin, rivaroxaban offers predictable pharmacokinetics, requires no routine blood monitoring (INR testing), and has fewer dietary restrictions, making it a preferred choice for many patients and physicians. If you are looking to buy Xarelto online, dutypills.ovh offers genuine rivaroxaban at competitive prices with reliable shipping.
Dosage and direction
Xarelto is taken orally once daily or twice daily depending on the specific condition being treated and the phase of therapy. For stroke prevention in atrial fibrillation, the standard dose is 20 mg once daily with the evening meal. For DVT/PE treatment, the typical regimen begins with 15 mg twice daily with food for the first 21 days, followed by 20 mg once daily with food for continued treatment. For VTE prophylaxis after orthopedic surgery, 10 mg once daily is prescribed. Higher doses (15 mg and 20 mg) should always be taken with food to ensure adequate absorption. Tablets should be swallowed whole; however, if a patient has difficulty swallowing, the tablet may be crushed and mixed with applesauce immediately before administration, followed by food. Dosage adjustments may be required for patients with renal impairment. Follow your doctor's specific instructions carefully and do not alter the dose or discontinue treatment without medical guidance, as abruptly stopping Xarelto significantly increases the risk of thromboembolic events.
Precautions
Use Xarelto with caution if you have kidney or liver disease, active bleeding disorders, peptic ulcer disease, recent major surgery or trauma, or conditions that increase bleeding risk. Because rivaroxaban reduces the blood's clotting ability, avoid activities and sports that may cause injury or serious bleeding. Patients with prosthetic heart valves should not use Xarelto, as safety has not been established in this population. Spinal/epidural procedures carry a risk of spinal hematoma in anticoagulated patients, which can lead to long-term paralysis — inform all surgeons and anesthesiologists that you are taking Xarelto. Do not stop taking this medication without medical guidance, as sudden discontinuation increases the risk of stroke and blood clot formation. Regular kidney function monitoring is recommended, especially in elderly patients and those with renal impairment.
Contraindications
Xarelto is contraindicated in patients with active pathological bleeding (such as gastrointestinal or intracranial hemorrhage), severe hepatic impairment associated with coagulopathy, or known hypersensitivity to rivaroxaban or any of its excipients. It is not recommended during pregnancy due to the risk of pregnancy-related hemorrhage and potential fetal harm, or during breastfeeding unless specifically approved by a physician after careful risk-benefit assessment. Patients with mechanical prosthetic heart valves should not use rivaroxaban.
Possible side effect
Common side effects of Xarelto include easy bruising, minor bleeding from cuts that takes longer to stop, nosebleeds, bleeding gums, dizziness, headache, and gastrointestinal discomfort (nausea, stomach pain). More serious adverse effects that require immediate medical attention include signs of major bleeding: black or tarry stools, blood in urine (pink or brown), coughing up blood or coffee-ground-like material, vomiting blood, unusual or unexplained swelling, severe or persistent headache, extreme weakness, or fainting. Rare but serious complications include spinal/epidural hematoma (in patients undergoing spinal procedures) and severe allergic reactions. Seek emergency medical care immediately if heavy or uncontrollable bleeding occurs.
Drug interaction
Xarelto can interact with other anticoagulants (warfarin, heparin, enoxaparin), antiplatelet drugs (aspirin, clopidogrel), NSAIDs (ibuprofen, naproxen), antidepressants (SSRIs/SNRIs), and medications that affect hepatic CYP3A4 and P-glycoprotein pathways. Strong dual inhibitors of CYP3A4 and P-gp (such as ketoconazole, itraconazole, ritonavir, and clarithromycin) can significantly increase rivaroxaban levels and bleeding risk. Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St. John's Wort) may decrease rivaroxaban levels and reduce its anticoagulant effectiveness. Alcohol may further increase bleeding risk. Always inform your doctor about all medications, supplements, and herbal products you are taking.
Missed dose
If you miss a dose of Xarelto while on a once-daily regimen, take it as soon as you remember on the same day, then continue your regular schedule. Do not double the dose the following day. If you are on the twice-daily 15 mg regimen (initial DVT/PE treatment phase), you may take two 15 mg tablets together if a dose is missed, to ensure the full daily dose of 30 mg, as advised by your doctor. Resume your regular schedule the next day.
Overdose
Overdose of Xarelto may cause excessive or prolonged bleeding, which can be life-threatening. If overdose is suspected, seek immediate emergency medical attention. Activated charcoal may reduce absorption if administered soon after ingestion. A specific reversal agent, andexanet alfa, is available for emergency situations involving life-threatening or uncontrolled bleeding. Prothrombin complex concentrates may also be considered by emergency physicians.
Storage
Store Xarelto at room temperature between 20-25°C (68-77°F), protected from moisture, heat, and direct light. Keep out of reach of children and pets. Store in the original packaging until ready to use. Do not use Xarelto after the expiration date printed on the blister or bottle.
Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

2

